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T follicular helper (Tfh) cells help development of anti-
body responses via interleukin-21 (IL-21). Here we
show that activated human dendritic cells (DCs)
induced naive CD4+ T cells to become IL-21-
producing Tfh-like cells through IL-12. CD4+ T cells
primed with IL-12 induced B cells to produce immu-
noglobulins in a fashion dependent on IL-21 and
inducible costimulator (ICOS), thus sharing funda-
mental characteristics with Tfh cells. The induction
of Tfh-like cells by activated DCs was inhibited by
neutralizing IL-12. IL-12 induced two different
IL-21-producers: IL-21+IFN-g+T-bet+ Th1 cells and
IL-21+IFN-gT-bet non-Th1 cells, in a manner
dependent on signal transducer and activator of
transcription 4 (STAT4). IL-12 also regulated IL-21
secretion by memory CD4+ T cells. Thus, IL-12
produced by activated DCs regulates antibody
responses via developing IL-21-producing Tfh-like
cells and inducing IL-21 secretion from memory
CD4+ T cells. These data suggest that the develop-
mental pathway of Tfh cells differs between mice
and humans, which have considerable implications
for vaccine development.
INTRODUCTION
DCs sense microbial invasion and mobilize immune system
effectors (Banchereau and Steinman, 1998; Pulendran et al.,
2008; Reis e Sousa, 2004; Shortman and Liu, 2002). Upon recog-
nition of signals derived from the innate immune system and/or
microbial components, DCs migrate to secondary lymphoid
organs, i.e., spleen and lymph nodes, where they mature and
launch adaptive immunity. In particular, DC subsets play a
central role in the induction of distinct subsets of T cells
(Klechevsky et al., 2008; Ueno et al., 2007), which produce
different sets of cytokines necessary to clear distinct types of
microbes. T helper 1 (Th1) cells secrete interferon-g (IFN-g),
which allows for the control of intracellular microbes, Th2 cells158 Immunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc.secrete interleukin-4 (IL-4), which mediates immunity against
extracellular parasites (Mosmann and Coffman, 1989), and Th17
cells secrete IL-17A and IL-22, which control extracellular
bacteria (Bettelli et al., 2007; Ouyang et al., 2008). DCs produce
soluble factors or express cell surface molecules that regulate
the fate of T cells. For example, IL-12-secreting DCs potently
promote the development of Th1 cells (Trinchieri, 2003). On the
contrary, DCs lacking IL-12 secretion (Langenkamp et al.,
2000; Pulendran et al., 2001), particularly those expressing
OX40 ligand (Ito et al., 2005), promote Th2 responses.
Recently, a subset of CD4+ T cells, T follicular helper (Tfh) cells,
originally found in germinal centers (GCs) of secondary lymphoid
organs (Breitfeld et al., 2000; Campbell et al., 2001; Kim et al.,
2001; Schaerli et al., 2000), has been established as a critical
cell compartment specialized for the help of B cell responses
(Fazilleau et al., 2009; King et al., 2008; Vinuesa et al., 2005). Tfh
cells express chemokine (C-X-C motif) receptor 5 (CXCR5) and
migrate intoBcell follicle in response to its ligand,CXCL13,which
is produced by follicular DCs (Cyster et al., 2000; Gunn et al.,
1998). Together with activatedB cells and follicular DCs, Tfh cells
constitute germinal centers (GC), where B cells undergo isotype
switching and somatic hypermutation. This step permits the
selection of high-affinity B cells in GCs and leads to the genera-
tion of B cell memory (Allen et al., 2007; MacLennan, 1994). Tfh
cells provide help to B cells through several factors, including
CD40 ligand (CD40L) (Banchereau et al., 1994) and ICOS (Hutloff
et al., 1999). In particular, Tfh cells secrete the cytokine IL-21
(Bryant et al., 2007), which drives the growth, differentiation,
and isotype switching of B cells (Kuchen et al., 2007; Spolski
and Leonard, 2008). Furthermore, substantial evidence shows
that Tfh cells at extrafollicular sites also help B cell differentia-
tion into plasma cells in an IL-21-dependent fashion (King et al.,
2008; Odegard et al., 2008). However, the mechanism whereby
human DCs induce such IL-21-producing Tfh cells is unknown.
IL-21 itself provides a positive feedback loop to CD4+ T cells
and induces human (Caprioli et al., 2008) and mouse (Korn et al.,
2007; Nurieva et al., 2007; Suto et al., 2008; Vogelzang et al.,
2008; Wei et al., 2007) naive CD4+ T cells to secrete more IL-21.
The critical involvement of IL-21 for the induction of Tfh cells
in vivowas recently demonstrated inmousemodel (Nurieva et al.,
2008; Vogelzang et al., 2008). However, antigen-presenting cells
(APCs) including DCs or naive CD4+ T cells do not secrete IL-21,
therefore raising the question about the mechanism whereby
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Figure 1. IL-12 Potently Induces Naive CD4+ T Cells to Secrete IL-21
(A) Human naive CD4+ T cells cultured with allogeneic DCs stimulated with LPS or CD40L were restimulated at day 7 with PMA + ionomycin to test intracellular
IL-21 expression. Gated to FSChi activated CD4+ T cells. A representative out of three experiments.
(B) Activated CD4+ T cells sorted at day 7 were restimulated with CD3 + CD28 mAbs 24 hr to measure IL-21 secretion. Mean ± SD.
(C) Naive CD4+ T cells were stimulated by CD3 + CD28 mAbs with the supernatants of DCs activated by CD40L or TLR ligands. IL-21 production from activated
CD4+ T cells as in (B). Mean ± SD.
(D) Naive CD4+ T cells stimulated with CD3 + CD28 mAbs in the presence of the indicated cytokines and restimulated at day 7 with PMA + ionomycin for intra-
cellular IL-21 expression. A representative out of three experiments.
(E and F) IL-21 secretion from activated CD4+ T cells (E). Mean ± SD. (F) Experiments performed with cells from five different donors are shown. Paired t test.
(G) Expression of IL-21 in naive CD4+ T cells primed with IL-21 (30 ng/ml) as in (D) (left). IL-21 secretion from the activated CD4+ T cells (right). Mean ± SD.
A representative out of three experiments.APCs trigger the differentiation of IL-21-producing CD4+ T cells.
Recently, IL-6 has been shown to induce mouse CD4+ T cells to
secrete IL-21 (Dienz et al., 2009; Zhou et al., 2007), but whether
human CD4+ T cells share the same pathway is unknown.
In this study, we demonstrate that human DCs instruct naive
CD4+ T cells to become IL-21-producing Tfh-like cells through
thesecretionof IL-12, thus revealinganother substantial difference
in the immune systems of mice and humans (Mestas and Hughes,
2004). The nomenclature of ‘‘Tfh-like’’ cells is discussed later.
RESULTS
Activated DCs Induce Naive CD4+ T Cells
to Produce IL-21
Wefirst examinedwhether humanDCswere able to induce naive
CD4+ T cells to differentiate into CD4+ T cells secreting IL-21.DCs were generated by culturing monocytes with GM-CSF
and IL-4 for 6 days, and activated for 6 hr with LPS or CD40L-
transfected L cells. DCs were subsequently cultured (1.3 3 103
cells/well) with allogeneic naive CD4+ T cells (4 3 104 cells/
well). At day 7, CD4+ T cells were restimulated with PMA and
ionomycin for 6 hr in the presence of brefeldin A to assess intra-
cytoplasmic IL-21 expression. Very low amounts of intracyto-
plasmic IL-21 were detected in a small fraction of CD4+ T cells
primed with resting DCs (Figure 1A; 4.7% ± 2.7% of activated
CD4+ T cells; mean ± SEM; n = 3). In contrast, DCs exposed to
LPS or CD40L induced a larger fraction of CD4+ T cells to
express IL-21 (Figure 1A; 14.8% ± 1.6% and 22.5% ± 0.8% of
activated CD4+ T cells, respectively; mean ± SEM; n = 3). Note
that the expression of IL-21 was much higher on T cells that
have been primed with activated DCs than in T cells primed
with immature DCs (Figure 1A). Accordingly, CD4+ T cells primedImmunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc. 159
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IL-12 Regulates IL-21 Production by CD4+ T Cellswith activated DCs, but not with immature DCs, secreted high
amounts of IL-21 when restimulated for 24 hr with anti-CD3 +
anti-CD28 (Figure 1B).
Next, we examined whether the induction of IL-21-producing
CD4+ T cells was due to factor(s) secreted by activated DCs.
Thus, supernatants were collected from DCs stimulated for
48 hr with CD40L or various TLR ligands, including peptido-
glycan (PGN, TLR2 ligand), LPS (TLR4 ligand), flagellin (TLR5
ligand), and CL097 (TLR7 and 8 ligand). Supernatants from acti-
vated DC cultures were added to naive CD4+ T cells cultured on
plate-bound anti-CD3 + anti-CD28. After 7 days, the cells were
restimulated with anti-CD3 + anti-CD28 and production of
IL-21 was measured. Although supernatants from nonactivated
DCs did not induce naive CD4+ T cells to produce IL-21, super-
natants from activated DCs induced IL-21 secretion (Figure 1C).
The degree of induction varied with the DC activation signal.
CD40L-activated DCs were the most potent (IL-21: 3020 ±
970 pg/ml from 5 3 104 cells; mean ± SD; n = 3). LPS was the
most potent TLR-ligand (470 ± 120 pg/ml), followed by flagellin
(190 ± 21 pg/ml) and CL097 (110 ± 14 pg/ml). Supernatants
from DCs activated with PGN were poor at developing IL-21-
producing CD4+ T cells (26 ± 2 pg/ml).
Thus, DCs activated through TLRs or CD40 secrete soluble
factors that induce naive CD4+ T cells to produce IL-21.
IL-12 Induces Naive CD4+ T Cells to Secrete IL-21
To identify the cytokine(s) that induce IL-21 in naive CD4+
T cells, naive CD4+ T cells were stimulated for 7 days with
plate-bound anti-CD3 + anti-CD28 in the presence of cytokines
(10 ng/ml, except IFN-a at 500 IU/ml) known to be produced by
DCs (de Saint-Vis et al., 1998). IL-1b, IL-6, IL-10, IL-18, IL-27,
TNF-a, and IFN-a did not induce CD4+ T cells able to express
(Figure 1D) or secrete IL-21 (Figure 1E). However, IL-12 and
to a minor extent IL-23 promoted the development of CD4+
T cells able to produce IL-21. Upon reactivation through CD3 +
CD28, CD4+ T cells primed with IL-12 were able to secrete
nanogram amounts of IL-21 (3.3 ± 0.4 ng/ml in a culture of
53 104 cells/200 ml; mean ± SEM; n = 5), whereas those primed
with IL-23 secreted only picogram amounts (40 ± 4 pg/ml,
mean ± SEM; n = 5; Figure 1F). IL-27, another IL-12 family
cytokine, did not promote any IL-21 production. As reported
earlier (Caprioli et al., 2008), IL-21 induced naive CD4+ T cells
to secrete IL-21 at some extent, though when compared to
IL-12, the effect was marginal at all examined concentrations
(10–100 ng/ml) (Figure 1G). Of note, IL-12 also induced IL-21-
producing CD4+ T cells in cultures with serum-free medium
(X-VIVO15, data not shown), indicating that the induction of
IL-21-producing CD4+ T cells by IL-12 does not require serum
components.
Titration studies revealed that as little as 1 pg/ml of IL-12
allowed the generation of T cells capable of secreting measur-
able amounts of IL-21 (Figure 2A). In contrast, much larger
amounts of IL-23 were required to induce CD4+ T cells capable
of producing measurable amounts of IL-21. IL-21 or IL-23 did
not act in synergy with IL-12, as shown by the fact that neither
cytokines enhanced IL-21 secretion by CD4+ T cells primed with
suboptimal IL-12 (100 pg/ml; Figure S1 available online).
Thus, IL-12 potently induces the development of IL-21-
producing CD4+ T cells.160 Immunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc.IL-12 Induces Two Different Types of IL-21-Producing
CD4+ T Cells
IL-12 is a potent inducer of Th1 cells (Trinchieri, 2003) and
accordingly induced naive CD4+ T cells to secrete IFN-g
(Figure 2A). Indeed, 73% ± 2% of IL-21-positive CD4+ T cells
induced by IL-12 (10 ng/ml) coexpressed IFN-g (mean ± SEM;
n = 6; Figure 2B). However, IL-12 also promoted in a dose-
dependent manner the development of IL-21-expressing CD4+
T cells that lacked IFN-g expression (Figure 2C). Importantly,
IL-12 induced both IFN-g+IL-21+ and IFN-gIL-21+ cells from
highly purified cord blood naive CD4+ T cells (Figure 2D). To
determine the commitment to the Th1 pathway, the expression
of T-bet, a Th1-associated transcriptional factor, was analyzed.
Although IFN-g+IL-21+ CD4+ T cells as well as IFN-g+IL-21
expressed T-bet, IFN-gIL-21+ CD4+ T cells lacked T-bet ex-
pression (Figure 2E). Thus, IFN-g+IL-21+ cells induced by IL-12
are committed to the Th1 pathway. Notably, these two different
IL-21 producers were also present in blood and tonsils (Fig-
ure S2). Furthermore, consistent with the IL-12-induced CD4+
T cells, tonsillar IFN-g+IL-21+ CD4+ T cells expressed T-bet,
whereas IFN-gIL-21+ cells did not (Figure 2F).
All the IL-21-positive CD4+ T cells induced by IL-12 coex-
pressed TNF-a (Figure 2B). IL-21-positive CD4+ T cells induced
by IL-12 did not coexpress IL-17A. IL-23 also induced IL-21-
positive CD4+ T cells coexpressing TNF-a, but preferentially
induced IFN-gIL-21+ non-Th1 cells, which lacked T-bet expres-
sion (data not shown). IL-21-positive CD4+ T cells induced by
IL-23 did not coexpress IL-17A.
The observation that IL-12 potently induces IL-21 producers
prompted us to determine whether naive CD4+ T cells cultured
under Th2 and Th17-skewing conditions would become IL-21
producers as well. Naive CD4+ T cells were cultured for 7 days
with CD3 + CD28 mAbs in the presence of no cytokine (Th0),
IL-12 + anti-IL-4 (Th1), IL-4 + anti-IL-12 (Th2), or IL-23 + IL-1b +
IL-6 (Th17), and the secretion of IL-21 by activated CD4+ T cells
was analyzed. T cells polarized under Th1 conditions secreted
far more IL-21 than those polarized under Th17 conditions
(Figure 2G). Naive CD4+ T cells cultured under Th0 and Th2
conditions did not secrete detectable amounts of IL-21.
Naive CD4+ T Cells Primed with IL-12 Induce
B Cells to Produce Igs through IL-21
Inasmuch as Tfh cells help B cell immunoglobulin (Ig) production
through IL-21 (Bryant et al., 2007), we next examined whether
naive CD4+ T cells stimulated with IL-12 would share this prop-
erty. Thus, naive CD4+ T cells primed in the presence of IL-12
or other cytokines were sorted and cocultured (4 3 104 cells/
well) in the presence of CpG (TLR9 ligand) with autologous blood
IgD+CD27 naive B cells (4 3 104 cells/well) preactivated with
anti-IgM. Staphylococcal enterotoxin B (SEB), a superantigen,
was added to induce T-B interactions, and Igs were measured
in supernatants at day 14. CD4+ T cells primed without cytokine
failed to induce naive B cells to secrete Igs (Figure 3A, none). In
contrast, CD4+ T cells primed with IL-12 induced naive B cells
to secrete Igs, including IgM (2.7 ± 0.5 mg/ml, mean ± SEM;
n = 6), IgG (0.32 ± 0.08 mg/ml), and IgA (0.19 ± 0.04 mg/ml). Naive
B cells cocultured with CD4+ T cells primed with IL-23 pro-
duced much lower amounts of Igs (IgM, 0.02 ± 0.02 mg/ml; IgG,
0.02 ± 0.02 mg/ml; IgA, 0.02 ± 0.01 mg/ml; mean ± SEM; n = 6).
Immunity
IL-12 Regulates IL-21 Production by CD4+ T CellsFigure 2. IL-12 Induces Two Distinct Types of IL-21 Producers
(A) Naive CD4+ T cells were stimulated with CD3 + CD28 mAbs for 7 days in the presence of titrated amounts of IL-12 or IL-23. IL-21 and IFN-g secretion upon 24
hr CD3 + CD28 restimulation. Mean ± SD. A representative out of two experiments.
(B) Naive CD4+ T cells stimulated with CD3 + CD28 mAbs in the presence of 10 ng/ml IL-12 or IL-23 were restimulated at day 7 with PMA + ionomycin to test
intracellular cytokine expression. Gated to FSChi activated CD4+ T cells. A representative out of five experiments.
(C) Intracellular cytokine expression in CD4+ T cells primed with titrated amounts of IL-12 after restimulation with PMA + ionomycin. A representative out of two
experiments.
(D) Highly purified cord blood naive CD4+ T cells were stimulated for 7 days with CD3 + CD28 mAbs ± IL-12. Intracellular IL-21 and IFN-g expression upon stim-
ulation with PMA and ionomycin. A representative out of three experiments.
(E) Expression of T-bet and intracytoplasmic cytokines was analyzed in CD4+ T cells primed with IL-12, after restimulation with PMA + ionomycin. The levels of
T-bet expression in IL-21+IFN-g (R1), IL-21IFN-g+ (R2), and IL-21+IFN-g+ (R3) cells were compared to that in IL-21IFN-g cells (R0).
(F) Expression of T-bet and intracytoplasmic cytokines was analyzed in tonsillar CD4+ T cells stimulated with PMA + ionomycin.
(G) Naive CD4+ T cells were cultured for 7 days with CD3 + CD28mAbs under Th0, Th1, Th2, or Th17-skewing conditions. IL-21 secretion upon 24 hr CD3 + CD28
restimulation from activated CD4+ T cells. Mean ± SD.CD4+ T cells primed with IL-27 barely induced Ig production.
Consistent results were obtained with cells collected from three
different donors (Figure S3). Interaction between T cells and B
cells was required for optimal B cell help, as shown by the fact
that B cells produced less Igs in the absence of SEB (Figure S4).
Similarly, naive CD4+ T cells primed with IL-12 induced much
higher amounts of Ig production frommemory B cells than CD4+
T cells primed with IL-23 (Figure 3B; IL-12: IgM 31.9 ± 3.7 mg/ml,
IgG 23.0 ± 1.7 mg/ml, IgA 10.8 ± 2.6 mg/ml; IL-23: IgM 2.3 ±
1.6 mg/ml, IgG 4.5 ± 1.7 mg/ml, IgA 0.9 ± 0.3 mg/ml; mean ±SEM; n = 6). Furthermore, IL-12 promoted the development of
Tfh-like cells in a dose-dependent manner, as indicated by the
fact that CD4+ T cells primed with higher amounts of IL-12
induced more Ig secretion from B cells (Figure 3C).
To determine whether CD4+ T cells primed in the presence of
IL-12 help B cells through IL-21, soluble IL-21 receptor-Fc
chimeric protein was added to cultures of T and B cells. Blocking
IL-21 potently inhibited B cells to secrete Igs (Figure 3D).
Conversely, the addition of IL-21 into the cultures of CD4+
T cells primed in the absence of cytokines potently induced BImmunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc. 161
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IL-12 Regulates IL-21 Production by CD4+ T CellsFigure 3. CD4+ T Cells Primed in the Presence of IL-12 Help B Cells
(A) Naive B cells preactivated with anti-IgM were cultured in the presence of CpG and SEB with autologous CD4+ T cells primed with the indicated cytokines. Ig
titers in the supernatants were measured at day 14. Mean ± SEM; n = 6. Unpaired two-tailed t test. A representative out of three experiments.
(B) Memory B cells were cultured in the presence of SEBwith autologous CD4+ T cells primed with the indicated cytokines. Ig levels at day 14. Mean ± SEM; n = 6.
Unpaired two-tailed t test. A representative out of three experiments.
(C) Ig secretion from memory B cells cultured with CD4+ T cells primed with titrated amounts of IL-12. Mean ± SEM; n = 4. A representative out of two
experiments.
(D) IL-21R-Fc was added to block IL-21 to the cocultures of memory B cells and CD4+ T cells primed with IL-12. Ig levels at day 14. Mean ± SEM; n = 6. Unpaired
two-tailed t test. A representative out of three experiments.
(E) Blocking of ICOS by ICOS-L-mIgFc during T-B cultures. Ig levels at day 14. Mean ± SEM; n = 6. Unpaired two-tailed t test. A representative out of three
experiments.cells to secrete Igs (Figure S5). Addition of ICOS-L-mIgFc protein
totally abrogated Ig secretion from B cells, indicating that Ig
secretion from B cells was dependent on ICOS expressed on
activated CD4+ T cells (Figure 3E). ICOS-ICOS-L interaction
appears to be critical for the cognate interaction between B
and T cells, because ICOS-L-mIgFc protein abrogated their
cluster formation in the culture and resulted in the B cell death
(data not shown). As shown previously, IL-12 induced the
expression of ICOS on CD4+ T cells (Wassink et al., 2004) at
higher amounts than IL-23 or IL-27 (Figure S6). Of note, IL-12
did not affect CXCR5 expression on activated naive CD4+
T cells (Figure S7). Naive CD4+ T cells primed in the presence
of any tested cytokines did not express CD57, a molecule
expressed by a fraction of Tfh cells in the GC (Figure S7).
Thus, CD4+ T cells primed with IL-12 share a fundamental
property of Tfh cells, which is to help B cells through IL-21 and
via the ICOS-ICOS-L interaction.
Bacteria-Activated DCs Induce IL-21-Producing
CD4+ T Cells through IL-12
We next examined whether DCs exposed to bacteria induce
naive CD4+ T cells to produce IL-21. DCs were incubated for162 Immunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc.6 hr with heat-killed bacteria including E. coli (gram negative),
S. aureus (gram positive), and P. gingivalis (gram positive), and
then cultured with allogeneic naive CD4+ T cells. Activated
CD4+ T cells sorted at day 7 were restimulated with CD3 +
CD28 mAbs to measure IL-21 secretion. CD4+ T cells primed
with E. coli-activated DCs secreted more IL-21 than those
primed with unstimulated DCs (Figure 4A). DCs stimulated with
S. aureus or P. gingivalis were also able to induce IL-21 produc-
tion by CD4+ T cells though less potently than did E. coli-acti-
vated DCs. Indeed, E. coli-activated DCs secreted far more
IL-12p70 and IL-23 than did S. aureus and P. gingivalis-activated
DCs (Figure 4B). Addition of IL-12p40-blocking mAb, which
inhibits both IL-12 and IL-23, to the cocultures of E. coli-acti-
vated DCs and T cells inhibited IL-21 secretion by CD4+ T cells
(Figure 4C). Notably, addition of IL-12p70-blocking mAb, which
inhibits IL-12 alone, was sufficient to inhibit IL-21 secretion
(85% ± 5% inhibition by IL-12p70 blocking; mean ± SEM; n = 5).
Blocking of IFN-a, IFN-g, IL-1b, or TNF-a did not inhibit IL-21
secretion (Figure S8). IL-12p70 blocking also resulted in a sub-
stantial decrease of IL-21 secretion by CD4+ T cells stimulated
with DCs exposed to S. aureus (87% ± 3% decrease, n = 4) or
P. gingivalis (80% ± 9% decrease, n = 4). Overall, anti-IL-12p40
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Figure 4. DCs Exposed to Bacteria Induce IL-21-Producing Tfh-like Cells through IL-12
(A) IL-21 secretion from naive CD4+ T cells cultured with allogeneic DCs exposed to heat-killed bacteria. Mean ± SD. A representative out of five experiments.
(B) IL-12 and IL-23 secretion from DCs exposed to heat-killed bacteria. Mean ± SD. A representative out of five experiments.
(C) IL-21 secretion of CD4+ T cells primed with bacteria-exposed DCs in the presence of IL-12p40 or IL-12p70 mAb. Mean ± SD. A representative out of five
experiments.
(D) IL-21 secretion of CD4+ T cells primed with CD40L- or LPS-activated DCs in the presence of IL-12p70 mAb. Mean ± SD. A representative out of three experi-
ments.
(E) IL-12 secretion from DCs exposed to CD40L or TLR ligands. Mean ± SD. A representative out of three experiments.
(F) Naive CD4+ T cells were cultured for 7 days with allogeneic bacteria-exposed DCs in the presence of IL-12p40 or IL-12p70 mAb. Activated CD4+ T cells were
sorted and cultured with autologousmemory B cells, and produced Igs were analyzed. Mean ± SEM; n = 6. Unpaired two-tailed t test. A representative out of four
experiments.and anti-IL-12p70 were equally potent at inhibiting the induction
of IL-21-producing CD4+ T cells (Figure S9). These results indi-
cate that the induction of IL-21 producers by bacteria-activated
DCs was mainly mediated by IL-12. This pathway was alsoshared by DCs stimulated with CD40L and LPS (Figure 4D). As
expected, CD40L-stimulated DCs, whose supernatant induced
naive CD4+ T cells to secrete the highest amounts of IL-21 (Fig-
ure 1C), produced the largest amount of IL-12p70 (Figure 4E).Immunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc. 163
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Figure 5. IL-12 Promotes IL-21 Secretion by Blood Memory CD4+ T Cells
(A and B) Fresh PBMCs were stimulated with SEB in the presence of IL-12p40 or IL-12p70 mAb. IL-21 (A) or the indicated cytokines (B) secreted cytokines during
48 hr cultures were measured. (A) Mean ± SD. Unpaired two-tailed t test. (B) Symbols represent results from seven different donors. Paired t test.
(C) Memory CD4+ T cells were stimulated with CD3 +CD28mAbs in the presence of the indicated cytokines. IL-21 secretion in the supernatants wasmeasured at
24 and 48 hr of culture. Mean ± SD.
(D) Naive CD4+ T cells were stimulated with CD3 + CD28 mAbs in the presence IL-12. IL-21 secretion in the supernatants was measured at the indicated time
points. Mean ± SD.Although LPS induced DCs to produce the highest amounts of
IL-12p70 among examined TLR ligands, PGN barely induced
DCs to secrete IL-12. This was consistent with the observation
that the culture supernatant of PGN-stimulated DCs poorly
induced CD4+ T cells to secrete IL-21 (Figure 1C).
CD4+ T cells primed with bacteria-activated DCs were able
to induce B cells to produce Igs (Figure 4F). The induction of Ig
secretion by B cells was significantly impaired when anti-IL-
12p40 was added during cocultures of DCs and T cells. Further-
more, blocking IL-12p70 was sufficient to inhibit the develop-
ment of Tfh-like cells. Thus, IL-12 secreted by DCs exposed to
bacteria is critical for the differentiation of naive CD4+ T cells
into Tfh-like cells.
Thus, DCs activated by CD40L, bacteria, and their compo-
nents (including TLR ligands) induce the development of IL-21-
producing Tfh-like cells through IL-12.
IL-12 Increases the Secretion of IL-21
by Memory CD4+ T Cells
We next determined whether IL-12 also controls IL-21 secretion
by memory CD4+ T cells. Fresh PBMCs from healthy adults pro-
duced high amounts of IL-21 when cultured with SEB for 48 hr
(740 ± 250 pg/ml; mean ± SEM; n = 7; Figures 5A and 5B). Block-
ing IL-12p70 during the 48 hr activation period resulted in a
significant decrease of IL-21 secretion (110 ± 30 pg/ml; n = 7;
p < 0.05; Figure 5B). Blocking of both IL-12 and IL-23 with
anti-IL-12p40 decreased IL-21 secretion (120 ± 40 pg/ml; n =
6) to a degree comparable to blocking IL-12 alone. The secretion164 Immunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc.of IFN-g was also strongly inhibited with anti-IL-12p70, but
blocking IL-12 did not alter the secretion of other cytokines
including IL-2, IL-5, and IL-17A (Figure 5B). Thus, blocking
IL-12 specifically inhibited the secretion of both IL-21 and IFN-g.
To further confirm the IL-12-dependent induction of IL-21
secretion by memory CD4+ T cells, memory CD4+ T cells were
sorted and stimulated with anti-CD3 + anti-CD28 in the presence
of IL-12, IL-23, and IL-27. As shown in Figure 5C, IL-12 potently
induced memory CD4+ T cells to secrete IL-21 between 24 and
48 hr after stimulation, indicating the delayed mode of action.
Naive CD4+ T cells did not secrete detectable amounts of
IL-21 during the first 72 hr (Figure 5D). These observations indi-
cate that IL-12 directly acts on memory CD4+ T cells and
promotes the secretion of IL-21.
Induction of IL-21 Producers by IL-12
Is Dependent on STAT4
IL-12 activates multiple signal transduction pathways, including
signal transducer and activator of transcription 3 (STAT3) and
STAT4 (reviewed in Watford et al., 2004). Induction of IFN-g in
CD4+ T cells by IL-12 is largely dependent on the activation of
STAT4 (Kaplan et al., 1996; Thierfelder et al., 1996). To determine
the contribution of STAT3 and STAT4 for the induction of IL-21,
STAT3 and STAT4 were targeted in naive CD4+ T cells by trans-
fecting siRNA. siRNA transfection of naive CD4+ T cells stimu-
lated with anti-CD3 + anti-CD28 mAbs for 5–7 days resulted in
a decrease of the expression of STAT3 and STAT4 by approxi-
mately 60% at 24 hr after transfection (Figure 6A). Transfected
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Figure 6. IL-12 Induce IL-21 Producers through STAT4
(A) Naive CD4+ T cells stimulated with CD3 + CD28 mAbs for 5–7 days were transfected with siRNA specific for STAT3 or STAT4. The levels of STAT3 and STAT4
expression at 24 hr after transfection were analyzed by flow cytometry. Cells transfected with control siRNA (gray), STAT3 siRNA (blue), and STAT4 siRNA (red)
are shown. Black histogram represents staining with control isotype. Gated to AQUAFSChi activated CD4+ T cells. A representative out of three experiments.
(B) Transfected CD4+ T cells were cultured for 48 hr in the presence of IL-12, IL-23, or IL-21. Activated CD4+ T cells were then restimulatedwith CD3 +CD28mAbs
for 24 hr to measure IL-21 secretion. Mean ± SD. A representative out of three experiments.
(C) After 48 hr culture with IL-12, IL-23, or IL-21, the expression of IL-21 was analyzed after 6 hr restimulation with PMA + ionomycin. Gated to AQUAFSChi
activated CD4+ T cells. A representative out of three experiments.
(D) Percentages of IL-21-expressing CD4+ T cells in three independent experiments. Paired t test.
(E) Percentages of IFN-g+IL-21+ and IFN-gIL-21+ cells in STAT4 siRNA-transfected CD4+ T cells cultured with IL-12. Paired t test.CD4+ T cells were stimulated for 48 hr with CD3 + CD28 mAbs in
the presence of IL-12, IL-23, or IL-21. Activated CD4+ T cells
were sorted and then restimulated with CD3 + CD28 mAbs for
24 hr to measure IL-21 secretion. STAT4 blocking substantially
decreased IL-21 production by CD4+ T cells stimulated by
IL-12, but not by CD4+ T cells stimulated by IL-23 or IL-21
(Figure 6B). In contrast, the induction of IL-21 producers in
response to IL-21 was largely dependent on STAT3, an observa-
tion consistent with previous studies performed with mouse
(Nurieva et al., 2008; Wei et al., 2007; Zhou et al., 2007) and
human (Caprioli et al., 2008) CD4+ T cells. Furthermore, IL-23
also induced IL-21 producers in a STAT3-dependent manner.The induction of IL-21-expressing CD4+ T cells was further
analyzed by intracytoplasmic cytokine staining after 6 hr restim-
ulation with PMA and ionomycin. As expected, STAT4 blocking
inhibited the development of IFN-g-expressing CD4+ T cells in
response to IL-12 (Figure 6C; 68% ± 5% with control versus
54% ± 5% with STAT4 blocking; mean ± SEM; n = 3; p <
0.005). Consistent with the analysis of IL-21 production, the
development of IL-21-expressing CD4+ T cells by IL-12 was
largely dependent on STAT4 (Figures 6C and 6D). Furthermore,
STAT4 blocking inhibited the development of both IFN-g+
IL-21+ Th1 cells and IFN-gIL-21+ non-Th1 cells (Figure 6E;
IFN-g+IL-21+: 13.0% ± 0.2% with control versus 4.8% ± 0.4%Immunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc. 165
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21+: 7.3% ± 0.2% with control versus 3.8% ± 0.2% with
STAT4 blocking; p < 0.01). STAT3 blocking only marginally
decreased the generation of IL-21-expressing CD4+ T cells by
IL-12 (Figure 6D). In contrast, the development of IL-21-express-
ing CD4+ T cells by IL-23 and IL-21 was confirmed to be depen-
dent on STAT3, but not on STAT4 (Figures 6C and 6D).
Thus, the development of human IL-21-producing CD4+
T cells by IL-12 is largely dependent on STAT4.
DISCUSSION
Our study addresses how human DCs induce the differentiation
of naive CD4+ T cells into T cells with a capacity to help B cells
through IL-21. We show that IL-12 is a key factor derived from
human DCs to drive differentiation. Such IL-21-producing
CD4+ T cells induced by IL-12 share fundamental characteristics
with tonsillar Tfh cells, including (1) production of a large amount
of IL-21, (2) capacity to help B cells in a manner dependent on
IL-21 and ICOS, and (3) presence of two distinct IL-21+CD4+
T cell subsets, IFN-g+IL-21+ and IFN-gIL-21+.
The definition of Tfh cells still remains controversial. As the
name indicates, Tfh cells are generally defined by their location
in vivo, i.e., at the follicular sites of secondary lymphoid organs.
However, in a similar concept applied to other Th subsets, Tfh
cells are also defined by their exclusive functions: i.e., the secre-
tion of IL-21 and the function to help B cells through IL-21, rather
than by their location. This function-based nomenclature fits well
with a recent view of Tfh ‘‘subsets,’’ where Tfh cells are derived
from different Th lineages and differently regulate B cell immunity
(Fazilleau et al., 2009). Furthermore, an increasing number of
studies indicates that IL-21-producing ‘‘extrafollicular’’ Tfh cells
(King et al., 2008; Odegard et al., 2008) and pre-GC Tfh cells
(Fazilleau et al., 2009) share many characteristics with GC Tfh
cells. This further supports the nomenclature of Tfh cells as a
T cell subset specialized for B cell help, particularly through
the secretion of IL-21. The nomenclature of ‘‘Tfh’’ cells has not
been officially defined, so in this manuscript we called the IL-
21-producing CD4+ T cells with the capacity to help B cells
‘‘Tfh-like’’ cells for the sake of simplicity.
Several findings are shown that together establish the signifi-
cance of IL-12 in the development of IL-21-producing Tfh-like
cells in humans. (1) Soluble factors secreted by activated DCs
efficiently induce naive CD4+ T cells to become cells able to
secrete IL-21. (2) IL-12 is the most efficient DC-derived cytokine
able to induce IL-21 in CD4+ T cells. This finding extends a
previous observation showing that Th1-promoting culture condi-
tion induces IL-21 in human naive CD4+ T cells (Volpe et al.,
2008). (3) DCs activated by TLR-ligands, CD40L, and bacteria
secrete IL-12, and potently induce naive CD4+ T cells to secrete
IL-21. (4) Blocking IL-12 during cocultures of activated DCs and
naive CD4+ T cells results in a significant inhibition of IL-21 secre-
tion from primed CD4+ T cells as well as the development of Tfh-
like cells. And (5) CD4+ T cells generated in vitro by culturing
naive CD4+ T cells with IL-12 are able to help B cells to secrete
Igs in a manner dependent on IL-21. Among different TLR
agonists tested, TLR4 agonists (LPS and gram-negative bacteria
such as E. coli) were the most potent activators of DCs with
respect to inducing naive CD4+ T cells to secrete IL-21. In166 Immunity 31, 158–169, July 17, 2009 ª2009 Elsevier Inc.contrast, TLR2 agonists (PGN and gram-positive bacteria such
as S. aureus and P. gingivalis) were poor activators, which is
consistent with their poor ability to induce DCs to produce
IL-12 (Gerosa et al., 2008; Pulendran et al., 2001). Furthermore,
IL-12 was found to act as a critical factor not only for the devel-
opment of IL-21-producing CD4+ T cells but also as a factor
helping memory CD4+ T cells to secrete IL-21. Thus, human
DCs appear to regulate antibody responses through the secre-
tion of IL-12.
Importantly, IL-12 induces both IFN-g+IL-21+ Th1 cells and
IFN-gIL-21+ non-Th1 cells from highly purified cord blood naive
CD4+ T cells. Induction of these two different IL-21 producers
might be best explained by a potential heterogeneity within naive
CD4+ T cells, as recently shown by CD161-expressing naive
CD4+ T cells as progenitor of Th17 cells (Cosmi et al., 2008).
The development of IL-21-producing CD4+ T cells by IL-12 is
largely dependent on STAT4. STAT4 regulates the development
of both IFN-g+IL-21+ Th1 cells and IFN-gIL-21+ non-Th1 cells.
The contribution of STAT3 in the development of IL-21 producers
by IL-12 is marginal. In contrast, IL-23 and IL-21 induce IL-21
producers in a STAT3-dependent fashion. These two cytokines
mainly induce IFN-gIL-21+ non-Th1 cells. Thus, both STAT3
and STAT4 are involved in the induction of IL-21 in human
CD4+ T cells, and distinct signaling pathways appear to induce
different types of IL-21 producers. Our findings are corroborated
by the demonstration that STAT3-deficient CD4+ T cells
obtained from hyper IgE syndrome patients can secrete IL-21
(Milner et al., 2008).
The IL-12-IL-21 axis demonstrated herein with human cells
does not appear to be shared by mouse cells, inasmuch as
several studies showed that IL-12 does not induce mouse naive
CD4+ T cells to secrete IL-21 (Dienz et al., 2009; Suto et al., 2008;
Wei et al., 2007). In mice, IL-6 and IL-21 have been reported as
critical factors in the generation of IL-21-producing CD4+
T cells both in vitro and in vivo (Dienz et al., 2009; Korn et al.,
2007; Nurieva et al., 2007; Suto et al., 2008; Zhou et al., 2007).
Because both IL-6 and IL-21 signal through STAT3, it has been
concluded that STAT3 is critical in the generation of IL-21-
producing CD4+ T cells. Indeed, STAT3-deficient mice severely
impaired the development of Tfh cells (Nurieva et al., 2008;
Wei et al., 2007). Thus, the distinct mechanism in the develop-
ment of IL-21-producing CD4+ T cells adds to the list of differ-
ences between the human and mouse immune systems (Mestas
and Hughes, 2004).
Taken together, our results indicate that IL-12, which activates
cellular immunity by inducing Th1 cells, also contributes to
humoral immunity indirectly through the generation of Tfh cells.
Actually, IL-12 from activated DCs also acts directly on activated
naive B cells together with IL-6 to induce their differentiation into
plasma cells (Dubois et al., 1998). Therefore, when DCs form the
‘‘me´nage a` trois’’ complex with antigen-specific T cells and
B cells (Qi et al., 2006), IL-12 secreted from DCs may act on
both CD4+ T cells and B cells to optimize the development of
antibody responses (Figure S10).
The discovery of the role of IL-12 in humans for the induction
and activation of IL-21-producing Tfh cells may have a profound
impact on the development of new therapies. Identifying adju-
vants that induce DCs to secrete IL-12 might improve vaccines
aiming at efficient induction of neutralizing antibodies. Indeed,
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enhances the induction of specific antibody responses in vivo
when used as vaccine adjuvant (Hirao et al., 2008; Schadeck
et al., 2006; van der Meide et al., 2002). In contrast, blocking of
IL-12 might be beneficial to prevent the development of auto-
reactive B cells in autoimmune diseases.
EXPERIMENTAL PROCEDURES
Isolation of CD4+ T Cells and B Cells
The study was approved by the Institutional Review Board of Baylor Health
Care System. Informed consent was obtained from healthy subjects for the
collection of blood apheresis samples. PBMCs were purified from apheresis
blood samples obtained from adult volunteers. CD4+ T cells were first enriched
by negative selection with purified CD8 (HIT8a), CD11b (LM1/2), CD11c
(B-ly6), CD14 (M5E2), CD15 (W6D3), CD16 (3G8), CD19 (J4.119), CD45RO
(UCHL1), CD56 (C218), and HLA-DR (B8.12.2) mAbs and Dynabeads Pan
Mouse IgG (Dynal). Naive CD4+ T cells were further purified by sorting with
FACSAria (BD) as CCR7+CD8CD56HLA-DRCD45RA+CD4+ cells. Memory
CD4+ T cells were directly sorted from PBMCs as CD8CD56CD45RACD4+
cells. Cord blood naive CD4 T cells were sorted from frozen cells (AllCells) as
CCR7+CD8CD56HLA-DRCD45RA+ CD4+. Cell purity was >99%.
B cells were first enriched from apheresis PBMCs by positive selection with
CD19MicroBeads (Miltenyi). Then, naive and memory B cells were sorted with
FACSAria as IgD+CD27CD3CD11cCD14 cells and CD27+CD3CD11c
CD14 cells, respectively. Cell purity was >98%.
Coculture of DCs and Naive CD4+ T Cells
Monocytes were isolated from PBMCs with Monocyte Isolation Kit II (Miltenyi).
DCs were generated by culturing monocytes with 50 ng/ml IL-4 (R&D) and
100 ng/ml GM-CSF (Leukine) At day 6, DCs were stimulated with irradiated
CD40L-transfected L cells, PGN (5 mg/ml), LPS (50 ng/ml), flagellin (20 ng/ml),
CL097 (imidazoquinoline compound; 5 mg/ml), heat killed-Escherichia coli
(108/ml), heat killed-Staphylococcus aureus (108/ml, InvivoGen), or heat
killed-Porphyromonas gingivalis (108/ml, InvivoGen). After 6 hr stimulation,
DCs were harvested and carefully washed; DCs stimulated with CD40L-trans-
fected L cells were sorted as CD11c+CD40L DCs. Activated DCs (1.3 3 103
cells/well) were cultured for 7 days with allogeneic naive CD4+ T cells (43 104
cells/well) in RPMI complete medium. In some experiments, 10 mg/ml anti-IL-
12p40 (C8.6) or anti-IL-12p70 (M122) blocking mAbs were added to the
culture. For the assessment of IL-12 secretion, DCs harvested at 6 hr stimula-
tion were cultured for another 24 hr in flat-bottom 96-well plates (23 105 cells/
well), and the secreted IL-12p70 and IL-23 weremeasured in triplicate cultures
by ELISA (eBiosciences).
Stimulation of Naive CD4+ T Cells via CD3 and CD28
Naive or memory CD4+ T cells (1 3 105 cells/well) were stimulated with plate-
bound CD3 mAb (5 mg /ml, OKT3) and soluble CD28 mAb (1 mg/ml, CD28.2) in
flat-bottom 96-well plates in RPMI complete medium in the presence of IL-1b,
IL-4, IL-6, IL-10, IL-12, IL-18, IL-27, and TNF-a (R&D), IL-21 (BioSource), IL-23
(eBiosciences) (10 ng/ml each or at indicated concentration), or IFN-a
(IFN-a2b. 500 IU/ml. Schering). In some experiments, anti-IL-4 (MP4-25D2)
or anti-IL-12p70 mAbs (2 mg/ml) were added to the culture.
Intracellular Staining
Naive CD4+ T cells stimulated for 7–9 days were restimulated with PMA (25 ng/
ml) and ionomycin (1 mg/ml) for 6 hr in the presence of GolgiPlug (BD) for the
last 4 hr. Cells were then fixed and permeabilized and the expressed cytokines
in the cytoplasm were analyzed with IL-21 PE or A647 (3A3-N2), IL-17A PE
(64DEC17), TNF-a APC (MAb11), and IFN-g APC (B27) mAbs. For T-bet
staining, cells were fixed/permeabilized with the Foxp3 Staining Buffer Set
(eBiosciences) and stained with T-bet A488 (4B10), IL-21 PE, and IFN-g
APC antibodies. In some experiments, dead cells were further excluded
from the analysis by labeling with cells LIVE/DEAD fixable Aqua (Invitrogen)
prior to fixation/permeabilization. Expression of each molecule was assessed
in activated CD4+ T cells (FSChi cells) with FlowJo software (TreeStar).Cytokine Secretion from Activated CD4+ T Cells
Activated naive CD4+ T cells were sorted at day 7–9 as FSChi cells (CD3+CD28
stimulation) or CD11cloFSChi cells (coculture with DCs). Sorted CD4+ T cells
were restimulated with CD3mAb and soluble CD28mAb in 96-well flat-bottom
plates (53104 cells/well) in Ysselmedia (Gemini) supplementedwith 10%FBS.
After 24 hr, the levels of produced cytokineswere assessed in triplicate cultures
by Luminex.
Coculture of T and B Cells
Activated CD4+ T cells were cocultured with autologous naive or memory
B cells (4 3 104 cells/well each) in 96-well round-bottom plates in Yssel
medium/10% FBS in the presence of endotoxin-reduced SEB (0.25 ng/ml).
Naive B cells were preactivated for 2 hr with 1 mg/ml rabbit anti-human IgM
(Irvine Scientific), andCpG typeB (0.5 mg/ml, ODN2006, InvivoGen) was added
to the culture. In some experiments, ICOS-L-mIgFc (Ancell), IgG1Fc, or
IL-21R/Fc (R&D) were added to the culture. Igs (IgM, IgG, and IgA) produced
in the cultures were analyzed by ELISA at day 6 or 14.
siRNA Transfection
Naive CD4+ T cells stimulated with CD3 + CD28mAbs for 5–7 days were trans-
fected with siRNA with the Human T cell Nucleofector Kit and Nucleofector II
device (Amaxa). siRNA to target STAT3 (s743), STAT4 (s13531), and silencer
select negative control #1 siRNA (Ambion) were used at 5 nM (0.5 nmol/5 3
106 cells/transfection). Cells were transferred at 6 hr after transfection to the
wells with CD3 + CD28 Abs. Cytokines (IL-12 [10 ng/ml], IL-23 [10 ng/ml], or
IL-21 [50 ng/ml]) were added to the culture 24 hr after transfection, and the
cytokine expression was analyzed 48 hr later.
STAT3 and STAT4 Staining
The expression of STAT3 and STAT4 was assessed 24 hr after siRNA transfec-
tion. After labeling with LIVE/DEAD fixable Aqua, cells were incubated with BD
cytofix buffer (BD) and then permeabilized with BD Phosflow Perm Buffer III
(BD). Cells were then incubated with anti-STAT3 APC (BD) and anti-STAT4
(Zymed) Abs, followed by incubation with goat anti-rabbit IgG FITC.
Statistics
The significance of the difference between groups in the experiments was
evaluated by two-tailed unpaired or paired t test. A value of p < 0.05 was
considered significant.
Development of Human IL-21 Bead-Based Assay
via Luminex Technology
See Supplemental Data.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and ten
figures and can be found with this article online at http://www.cell.com/
immunity/supplemental/S1074-7613(09)00272-6.
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